Chi-yuan Hsu, MD, MSc

Nephrologist

Dr. Chi-yuan Hsu is a nephrologist who cares for adults with kidney disease in both inpatient and outpatient settings.

Hsu's research investigates acute, chronic and end-stage renal disease, including strategies to improve outcomes for patients with these conditions. Questions that arise in the course of caring for patients have often motivated his research.

Hsu earned his medical degree from Harvard Medical School and a master's degree in clinical epidemiology from Harvard School of Public Health. He completed a residency in internal medicine at Beth Israel Hospital, followed by a fellowship in nephrology at Massachusetts General Hospital.

Hsu is a member of the American Society for Clinical Investigation, American Medical Association, American College of Physicians, American Society of Nephrology, National Kidney Foundation, International Society of Nephrology, Chinese American Society of Nephrology, Association of Specialty Professors and Renal Physicians Association. He is a fellow of the American College of Physicians and American Society of Nephrology, and has been voted a best doctor by San Francisco magazine, Marin Magazine and Castle Connolly, a consumer guide to preeminent U.S. health care. He is a professor at UCSF and the division chief of nephrology.

Clinics

Nephrology and Hypertension Faculty Practice
400 Parnassus Ave., B1 Plaza Level
San Francisco, CA 94143-0532
Phone: (415) 353-2507
Fax: (415) 353-2530

Hours: Monday to Friday
8 a.m. – 5 p.m.

Board Certification

Nephrology, American Board of Internal Medicine

Academic Title

Professor

More about Chi-yuan Hsu

Additional Languages

Cantonese
Mandarin

Education

Harvard University School of Medicine 1993
Harvard School of Public Health, M.Sc., Clinical Epidemiology 1999

Residencies

Boston's Beth Israel Hospital, Internal Medicine 1996

Fellowships

Massachusetts General Hospital, Nephrology 1998

Selected Research and Publications

  1. Zhan M, St Peter WL, Doerfler RM, Woods CM, Blumenthal JB, Diamantidis CJ, Hsu CY, Lash JP, Lustigova E, Mahone EB, Ojo AO, Slaven A, Strauss L, Taliercio JJ, Winkelmayer WC, Xie D, Fink JC. Patterns of NSAIDs Use and Their Association with Other Analgesic Use in CKD. Clin J Am Soc Nephrol. 2017 Nov 07; 12(11):1778-1786.
  2. Lee BJ, McCulloch CE, Grimes BA, Chandran S, Allen IE, Delgado C, Hsu CY. Refining the Policy for Timing of Kidney Transplant Waitlist Qualification. Transplant Direct. 2017 Aug; 3(8):e195.
  3. Bansal N, McCulloch CE, Lin F, Alper A, Anderson AH, Cuevas M, Go AS, Kallem R, Kusek JW, Lora CM, Lustigova E, Ojo A, Rahman M, Robinson-Cohen C, Townsend RR, Wright J, Xie D, Hsu CY. Blood Pressure and Risk of Cardiovascular Events in Patients on Chronic Hemodialysis: The CRIC Study (Chronic Renal Insufficiency Cohort). Hypertension. 2017 08; 70(2):435-443.
  4. Rebholz CM, Inker LA, Chen Y, Liang M, Foster MC, Eckfeldt JH, Kimmel PL, Vasan RS, Feldman HI, Sarnak MJ, Hsu CY, Levey AS, Coresh J. Risk of ESRD and Mortality Associated With Change in Filtration Markers. Am J Kidney Dis. 2017 Oct; 70(4):551-560.
  5. Ku E, Bakris G, Johansen KL, Lin F, Sarnak MJ, Campese VM, Jamerson K, Gassman JJ, Smogorzewski M, Hsu CY. Acute Declines in Renal Function during Intensive BP Lowering: Implications for Future ESRD Risk. J Am Soc Nephrol. 2017 Sep; 28(9):2794-2801.
  6. Grams ME, Yang W, Rebholz CM, Wang X, Porter AC, Inker LA, Horwitz E, Sondheimer JH, Hamm LL, He J, Weir MR, Jaar BG, Shafi T, Appel LJ, Hsu CY. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2017 Sep; 70(3):337-346.
  7. Carlos CA, McCulloch CE, Hsu CY, Grimes B, Pavkov ME, Burrows NR, Shahinian VB, Saran R, Powe NR, Johansen KL. Colon Cancer Screening among Patients Receiving Dialysis in the United States: Are We Choosing Wisely? J Am Soc Nephrol. 2017 Aug; 28(8):2521-2528.
  8. Park M, Hsu CY, Go AS, Feldman HI, Xie D, Zhang X, Mifflin T, Waikar SS, Sabbisetti VS, Bonventre JV, Coresh J, Nelson RG, Kimmel PL, Kusek JW, Rahman M, Schelling JR, Vasan RS, Liu KD. Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study. Clin J Am Soc Nephrol. 2017 May 08; 12(5):761-771.
  9. Lee BJ, Hsu CY. Acute kidney injury is important in the hospital and afterward. J Hosp Med. 2017 Feb; 12(2):126-127.
  10. Kurella Tamura M, Vittinghoff E, Hsu CY, Tam K, Seliger SL, Sozio S, Fischer M, Chen J, Lustigova E, Strauss L, Deo R, Go AS, Yaffe K. Loss of executive function after dialysis initiation in adults with chronic kidney disease. Kidney Int. 2017 04; 91(4):948-953.
  11. Sharief S, Hsu CY. The Transition From the Pre-ESRD to ESRD Phase of CKD: Much Remains to Be Learned. Am J Kidney Dis. 2017 Jan; 69(1):8-10.
  12. Ix JH, Katz R, Bansal N, Foster M, Weiner DE, Tracy R, Jotwani V, Hughes-Austin J, McKay D, Gabbai F, Hsu CY, Bostom A, Levey AS, Shlipak MG. Urine Fibrosis Markers and Risk of Allograft Failure in Kidney Transplant Recipients: A Case-Cohort Ancillary Study of the FAVORIT Trial. Am J Kidney Dis. 2017 Mar; 69(3):410-419.
  13. Ku E, Lipkowitz MS, Appel LJ, Parsa A, Gassman J, Glidden DV, Smogorzewski M, Hsu CY. Strict blood pressure control associates with decreased mortality risk by APOL1 genotype. Kidney Int. 2017 02; 91(2):443-450.
  14. Ku E, McCulloch CE, Mauer M, Gitelman SE, Grimes BA, Hsu CY. Association Between Blood Pressure and Adverse Renal Events in Type 1 Diabetes. Diabetes Care. 2016 12; 39(12):2218-2224.
  15. Scialla JJ, Asplin J, Dobre M, Chang AR, Lash J, Hsu CY, Kallem RR, Hamm LL, Feldman HI, Chen J, Appel LJ, Anderson CA, Wolf M. Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes. Kidney Int. 2017 01; 91(1):204-215.
  16. Inker LA, Coresh J, Sang Y, Hsu CY, Foster MC, Eckfeldt JH, Karger AB, Nelson RG, Liu X, Sarnak M, Appel LJ, Grams M, Xie D, Kimmel PL, Feldman H, Ramachandran V, Levey AS. Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis. Clin J Am Soc Nephrol. 2017 Jan 06; 12(1):69-78.
  17. Kurella Tamura M, Tam K, Vittinghoff E, Raj D, Sozio SM, Rosas SE, Makos G, Lora C, He J, Go AS, Hsu CY, Yaffe K. Inflammatory Markers and Risk for Cognitive Decline in Chronic Kidney Disease: The CRIC Study. Kidney Int Rep. 2017 Mar; 2(2):192-200.
  18. Hsu CY, Xie D, Waikar SS, Bonventre JV, Zhang X, Sabbisetti V, Mifflin TE, Coresh J, Diamantidis CJ, He J, Lora CM, Miller ER, Nelson RG, Ojo AO, Rahman M, Schelling JR, Wilson FP, Kimmel PL, Feldman HI, Vasan RS, Liu KD. Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression. Kidney Int. 2017 01; 91(1):196-203.
  19. Liu KD, Siew ED, Reeves WB, Himmelfarb J, Go AS, Hsu CY, Bennett MR, Devarajan P, Ikizler TA, Kaufman JS, Kimmel PL, Chinchilli VM, Parikh CR. Storage Time and Urine Biomarker Levels in the ASSESS-AKI Study. PLoS One. 2016; 11(10):e0164832.
  20. Bansal N, McCulloch CE, Lin F, Robinson-Cohen C, Rahman M, Kusek JW, Anderson AH, Xie D, Townsend RR, Lora CM, Wright J, Go AS, Ojo A, Alper A, Lustigova E, Cuevas M, Kallem R, Hsu CY. Different components of blood pressure are associated with increased risk of atherosclerotic cardiovascular disease versus heart failure in advanced chronic kidney disease. Kidney Int. 2016 12; 90(6):1348-1356.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.